Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study

Files

hdl_118551.pdf (290.66 KB)
  (Published version)

Date

2015

Authors

Worthley, S.
Hendriks, R.
Worthley, M.
Whelan, A.
Walters, D.
Whitbourn, R.
Meredith, I.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Cardiovascular Revascularization Medicine, 2015; 16(7):413-417

Statement of Responsibility

Stephen Worthley, Randall Hendriks, Matthew Worthley, Alan Whelan, DarrenL.Walters, Robert Whitbourn, Ian Meredith

Conference Name

Abstract

Several studies investigated the combination of bare metal stents in the main branch and drug-eluting balloons in the side branch in bifurcation lesions, but data on the combination of drug-eluting stents and drug-eluting balloons are scarce. We aim to assess the feasibility of provisional stenting with an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch.In this prospective, multi-center study conducted in 5 Australian sites, 35 patients with bifurcation lesions were enrolled. Angiographic and intravascular ultrasound assessments were conducted at 9 months; clinical follow-up was conducted until 12 months.The primary endpoint, late lumen loss in the side branch measured by quantitative coronary angiography, was 0.10±0.43mm. No binary restenosis was observed. One patient died; 3 myocardial infarctions (one suspected and two in non-target vessels) and one target lesion revascularization occurred. No probable or definite stent thrombosis was observed.The combination of an everolimus-eluting stent in the main branch and a paclitaxel-eluting balloon in the side branch appears to be a safe, effective and novel treatment option for bifurcation lesions.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).

License

Grant ID

Call number

Persistent link to this record